Stereological analysis of acute lung injury

European Respiratory Review

Volumn 15, Issue 101, 2006, Pages 115-121

  Ochs, M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

Acute lung injury; Microscopy; Morphometry; Stereology

Indexed keywords

LUNG SURFACTANT;

ACUTE LUNG INJURY; BIOPHYSICS; CHEMICAL ANALYSIS; ELECTRON MICROSCOPY; HISTOPATHOLOGY; HUMAN; LUNG ALVEOLUS CELL; LUNG EDEMA; LUNG GAS EXCHANGE; LUNG STRUCTURE; MICROSCOPY; PNEUMATIC TOOL; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RANDOM SAMPLE; REVIEW; STEREOMETRY;

EID: 34447124467     PISSN: 09059180     EISSN: None     Source Type: Journal    
DOI: 10.1183/09059180.00010102     Document Type: Review

References (86)

1. Weibel ER. Stereological Methods: Practical Methods for Biological Morphometry. New York, Academic Press, 1979.
2. Gundersen HJG, Bendtsen TF, Korbo L, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988; 96: 379-394.
3. Gundersen HJG, Bagger P, Bendtsen TF, et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988; 96: 857-881.
4. Cruz-Orive LM, Weibel ER. Recent stereological methods for cell biology: a brief survey. Am J Physiol Lung Cell Mol Physiol 1990; 258: L148-L156.
5. Mayhew TM. The new stereological methods for interpreting functional morphology from slices of cells and organs. Exp Physiol 1991; 76: 639-665.
6. Howard CV, Reed MG. Unbiased Stereology. Three-dimensional Measurement in Microscopy. 2nd Edn. Oxford, Bios, 2005.
7. Nyengaard JR, Gundersen HJG. Sampling for stereology in lungs. Eur Respir Rev 2006; 15: 107-114.
8. Ochs M. A brief update on lung stereology. J Microsc 2006; 222: 188-200.
9. Weibel ER, Hsia CCW, Ochs M. How much is there really? Why stereology is essential in lung morphometry. J Appl Physiol 2007; 102: 459-467.
10. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE. Acute respiratory distress in adults. Lancet 1967; 2: 319-323.
11. Bernard GR, Artigas A, Brigham KL, et al. The American European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149: 818-824.
12. Ware LB, Matthay MA. The acute respiratory distress syndrome. New Engl J Med 2000; 342: 1334-1349.
13. Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury. Am J Respir Crit Care Med 2003; 167: 1027-1035.
14. De Perrot M, Liu M, Keshavjee S. Ischemia-reperfusion-induced lung injury. Am J Respir Crit Care Med 2003; 167: 490-511.
15. Van Raemdonck D, Strüber M, Venuta F, Vlasselaers D, Wisser W, Erasmus ME. Strategies in the prevention and the treatment of ischaemia-reperfusion injury after lung transplantation. Eur Respir Mon 2004; 29: 66-88.
16. Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT working group on primary lung graft dysfunction part II: definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2005; 24: 1454-1459.
17. Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. New Engl J Med 2005; 353: 1685-1693.
18. MacCallum NS, Evans TW. Epidemiology of acute lung injury. Curr Opin Crit Care 2005; 11: 43-49.
19. Lewandowski K, Lewandowski M. Epidemiology of ARDS. Minerva Anestesiol 2006; 72: 473-477.
20. Bachofen M, Weibel ER. Alterations of the gas exchange apparatus in adult respiratory insufficiency associated with septicemia. Am Rev Respir Dis 1977; 116: 589-615.
21. Anderson WR, Thielen K. Correlative study of adult respiratory distress syndrome by light, scanning, and transmission electron microscopy. Ultrastruct Pathol 1992; 16: 615-628.
22. Albertine KH. Histopathology of pulmonary edema and the acute respiratory distress syndrome. In: Matthay MA, Ingbar DH, eds. Pulmonary Edema. New York, Marcel Dekker, 1998; pp. 37-83.
23. Tomashefski JF Jr. Pulmonary pathology of the acute respiratory distress syndrome. Diffuse alveolar damage. In: Matthay MA, ed. Acute Respiratory Distress Syndrome. New York, Marcel Dekker, 2003; pp. 75-114.
24. Knight PR, Rotta AT. Acute lung injury: etiologies and basic features. In: Notter RH, Finkelstein JN, Holm BA, eds. Lung Injury. Mechanisms, Pathophysiology, and Therapy. Boca Raton, Taylor and Francis, 2005; pp. 67-109.
25. Menezes SLS, Bozza PT, Castro Faria Neto HC, et al. Pulmonary and extrapulmonary acute lung injury: inflammatory and ultrastructural analyses. J Appl Physiol 2005; 98: 1777-1783.
26. Piantadosi CA, Schwartz DA. The acute respiratory distress syndrome. Ann Intern Med 2004; 141: 460-470.
27. Mendez JL, Hubmayr RD. New insights into the pathology of acute respiratory failure. Curr Opin Crit Care 2005; 11: 29-36.
28. Lewis JF, Novick RJ, Veldhuizen RAW. Surfactant in Lung Injury and Lung Transplantation. New York, Springer, 1997.
29. Putman E, Van Golde LMG, Haagsman HP. Toxic oxidant species and their impact on the pulmonary surfactant system. Lung 1997; 175: 75-103.
30. Baker CS, Evans TW, Randle BJ, Haslam PL. Damage to surfactant-specific protein in acute respiratory distress syndrome. Lancet 1999; 353: 1232-1237.
31. Notter RH. Lung Surfactants. Basic Science and Clinical Applications. New York, Marcel Dekker, 2000.
32. Günther A, Ruppert C, Schmidt R, et al. Surfactant alteration and replacement in acute respiratory distress syndrome. Respir Res 2001; 2: 353-364.
33. Lewis JF, Veldhuizen R. The role of exogenous surfactant in the treatment of acute lung injury. Annu Rev Physiol 2003; 65: 613-642.
34. Wang Z, Holm BA, Matalon S, Notter RH. Surfactant activity and dysfunction in lung injury. In: Notter RH, Finkelstein JN, Holm BA, eds. Lung Injury. Mechanisms, Pathophysiology, and Therapy. Boca Raton, Taylor and Francis, 2005; pp. 297-352.
35. Finkelstein JN, O'Reilly MA, Holm BA, Chess PR, Notter RH. Cell and animal models of lung injury. In: Notter RH, Finkelstein JN, Holm BA, eds. Lung Injury. Mechanisms, Pathophysiology, and Therapy. Boca Raton, Taylor and Francis, 2005; pp. 353-404.
36. Montaner JSG, Tsang J, Evans KG, et al. Alveolar epithelial damage. A critical difference between high pressure and oleic acid-induced low pressure pulmonary edema. J Clin Invest 1986; 77: 1786-1796.
37. Bachofen H, Weibel ER. Structure-function relationships in the pathogenesis of pulmonary edema. In: Weir EK, Reeves JT, eds. Pulmonary Edema. Armonk, Futura, 1998; pp. 17-33.
38. Martin TR. Neutrophils and lung injury: getting it right. J Clin Invest 2002; 110: 1603-1605.
39. Parker JC, Townsley MI. Evaluation of lung injury in rats and mice. Am J Physiol Lung Cell Mol Physiol 2004; 286: L231-L246.
40. Fehrenbach H, Brasch F, Uhlig S, et al. Early alterations in intracellular and alveolar surfactant of the rat lung in response to endotoxin. Am J Respir Crit Care Med 1998; 157: 1630-1639.
41. Ochs M, Nenadic I, Fehrenbach A, et al. Ultrastructural alterations in intraalveolar surfactant subtypes after experimental ischemia and reperfusion. Am J Respir Crit Care Med 1999; 160: 718-724.
42. Ochs M, Fehrenbach H, Nenadic I, et al. Preservation of intraalveolar surfactant in a rat lung ischaemia/reperfusion injury model. Eur Respir J 2000; 15: 526-531.
43. Fehrenbach A, Ochs M, Wahlers T, et al. Beneficial effect of lung preservation is related to ultrastructural integrity of tubular myelin after experimental ischemia and reperfusion. Am J Respir Crit Care Med 2000; 161: 2058-2065.
44. Bachofen H, Ammann A, Wangensteen D, Weibel ER. Perfusion fixation of lungs for structure-function analysis: credits and limitations. J Appl Physiol 1982; 53: 528-533.
45. Weibel ER. Morphometric and stereological methods in respiratory physiology, including fixation techniques. In: Otis AB, ed. Techniques in the Life Sciences. Techniques in Respiratory Physiology, part 1. County Clare, Elsevier, 1984; pp. 1-35.
46. Gil J. Histological preservation and ultrastructure of alveolar surfactant. Annu Rev Physiol 1985; 47: 753-763.
47. Gil J. Controlled and reproducible fixation of the lung for correlated studies. In: Gil J, ed. Models of Lung Disease. Microscopy and Structural Methods. New York, Marcel Dekker, 1990; pp. 3-22.
48. Bachofen H, Schürch S, Michel RP, Weibel ER. Experimental hydrostatic pulmonary edema in rabbit lungs: morphology. Am Rev Respir Dis 1993; 147:989-996.
49. Fehrenbach H, Ochs M. Studying lung ultrastructure. In: Uhlig S, Taylor AE, eds. Methods in Pulmonary Research. Basel, Birkhäuser, 1998; pp. 429-454.
50. Scherle W. A simple method for volumetry of organs in quantitative stereology. Mikroskopie 1970; 26: 57-60.
51. Michel RP, Cruz-Orive LM. Application of the Cavalieri principle and vertical sections method to lung: estimation of volume and pleural surface area. J Microsc 1988; 150: 117-136.
52. Yan X, Polo Carbayo JJ, Weibel ER, Hsia CCW. Variation of lung volume after fixation when measured by immersion or Cavalieri method. Am J Physiol Lung Cell Mol Physiol 2003; 284: L242-L245.
53. Staub NC, Nagano H, Pearce ML. Pulmonary edema in dogs, especially the sequence of fluid accumulation in lungs. J Appl Physiol 1967; 22: 227-240.
54. Staub NC. Pulmonary edema. Physiol Rev 1974; 54: 678-811.
55. Mühlfeld C, Müller K, Pallesen LP, et al. Impact of preservation solution on the extent of blood-air barrier damage and edema formation in experimental lung transplantation. Anat Rec 2007; 290: 491-500.
56. Fehrenbach H, Schepelmann D, Albes JM, et al. Pulmonary ischemia/reperfusion injury: a quantitative study of structure and function in isolated heart-lungs of the rat. Anat Rec 1999; 255: 84-99.
57. Fehrenbach A, Fehrenbach H, Wittwer T, Ochs M, Wahlers T, Richter J. Evaluation of pulmonary edema: stereological versus gravimetrical analysis. Eur Surg Res 2001; 33: 270-278.
58. Ochs M, Fehrenbach H, Richter J. Ultrastructure of canine type II pneumocytes during hypothermic ischemia of the lung: a study by means of conventional and energy filtering transmission electron microscopy. Anat Rec 2001; 263: 118-126.
59. Fehrenbach H. Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2001; 2: 33-46.
60. Clegg GR, Tyrrell C, McKechnie CR, Beers MF, Harrison D, McElroy MC. Coexpression of RTI40 with alveolar epithelial type II cell proteins in lungs following injury: identification of alveolar intermediate cell types. Am J Physiol Lung Cell Mol Physiol 2005; 289: L382-L390.
61. Elias H. Identification of structure by the common-sense approach. J Microsc 1972; 95: 59-68.
62. Weibel ER. The Pathway for Oxygen. Cambridge, Harvard University Press, 1984.
63. Maina JN, West JB. Thin and strong! The bioengineering dilemma in the structural and functional design of the blood-gas barrier. Physiol Rev 2004; 85: 811-844.
64. Gehr P, Bachofen M, Weibel ER. The normal human lung: ultrastructure and morphometric estimation of diffusion capacity. Respir Physiol 1978; 32: 121-140.
65. Wright JR. Immunomodulatory functions of surfactant. Physiol Rev 1997; 77: 931-962.
66. Hawgood S. Surfactant: Composition, structure, metabolism. In: Crystal RG, West JB, Weibel ER, Barnes PJ, eds. The Lung: Scientific Foundations. 2nd Edn. New York, Lippincott-Raven, 1997; pp. 557-572.
67. Griese M. Pulmonary surfactant in health and human lung diseases: state of the art. Eur Respir J 1999; 13: 1455-1476.
68. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005; 5: 58-68.
69. Mason RJ, Shannon JM. Alveolar type II cells. In: Crystal RG, West JB, Weibel ER, Barnes PJ, eds. The Lung: Scientific Foundations, 2nd Edn. New York, Lippincott-Raven, 1997; pp. 543-555.
70. Schmitz G, Müller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res 1991; 32: 1539-1570.
71. Weaver TE, Na CL, Stahlman M. Biogenesis of lamellar bodies, lysosome-related organelles involved in storage and secretion of pulmonary surfactant. Semin Cell Dev Biol 2002; 13: 263-270.
72. Dietl P, Haller T. Exocytosis of lung surfactant: from the secretory vesicle to the air-liquid interface. Annu Rev Physiol 2005; 67: 595-621.
73. Lewis JF, Jobe AH. Surfactant and the adult respiratory distress syndrome. Am Rev Respir Dis 1993; 147: 218-233.
74. Pison U, Böck JC, Pietschmann S, Veit S, Slama K. The adult respiratory distress syndrome: pathophysiological concepts related to the pulmonary surfactant system. In: Robertson B, Taeusch HW, eds. Surfactant Therapy for Lung Disease. New York, Marcel Dekker, 1995; pp. 169-197.
75. Jobe AH, Ikegami M. Surfactant and acute lung injury. Proc Assoc Am Physicians 1998; 110: 489-495.
76. Creuwels LAJM, Van Golde LMG, Haagsman HP. The pulmonary surfactant system: biochemical and clinical aspects. Lung 1997; 175: 1-39.
77. Costabel U. Bronchoalveolar lavage: a standardized procedure or a technical dilemma? Eur Respir J 1991; 4: 776-777.
78. Baughman RP. The uncertainties of bronchoalveolar lavage. Eur Respir J 1997; 10: 1940-1942.
79. Haslam PL, Postle AD, Raymondos K, Baker CS. Measurement of pulmonary surfactant components and function in bronchoalveolar lavage fluid. Eur Respir Rev 1999; 9: 43-69.
80. Tiroke AH, Bewig B, Haverich A. Bronchoalveolar lavage in lung transplantation. State of the art. Clin Transplant 1999; 13: 131-157.
81. Ochs M. Pulmonary surfactant preservation in experimental and clinical lung transplantation. In: Pandalai SG, ed. Recent research developments in respiratory and critical care medicine. Trivandrum, Research Signpost, 2001; pp. 59-81.
82. Gross NJ. Extracellular metabolism of pulmonary surfactant: the role of a new serine protease. Annu Rev Physiol 1995; 57: 135-150.
83. Ochs M, Schüttler M, Stichtenoth G, Herting E. Morphological alterations of exogenous surfactant inhibited by meconium can be prevented by dextran. Respir Res 2006; 7, 86: 1-8.
84. Ochs M, Nyengaard JR, Waizy H, Wahlers T, Gundersen HJG, Richter J. Alveolar type II cells and the intracellular surfactant pool in the human lung - a stereological approach. Am J Respir Crit Care Med 2001; 163: A731.
85. Waizy H, Fehrenbach H, Wahlers T, Richter J, Ochs M. Alterations in intracellular surfactant of the rat lung in response to ischemia-reperfusion injury. Am J Respir Crit Care Med 2001; 163: A732.
86. Fehrenbach A, Bube C, Hohlfeld JM, et al. Surfactant homeostasis is maintained in vivo during keratinocyte growth factor-induced rat lung type II cell hyperplasia. Am J Respir Crit Care Med 2003; 167: 1264-1270.